CN101703664B - Chinese medicinal composition for treating hyperosteogeny - Google Patents
Chinese medicinal composition for treating hyperosteogeny Download PDFInfo
- Publication number
- CN101703664B CN101703664B CN2009102203029A CN200910220302A CN101703664B CN 101703664 B CN101703664 B CN 101703664B CN 2009102203029 A CN2009102203029 A CN 2009102203029A CN 200910220302 A CN200910220302 A CN 200910220302A CN 101703664 B CN101703664 B CN 101703664B
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- hyperosteogeny
- medicinal composition
- chinese medicinal
- radix notoginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a Chinese medicinal composition for treating hyperosteogeny, which is prepared from althaeoides R. Knuth, fortune's drynaria rhizome, Chinese pyrola herb, East Asian tree fern rhizome, eucommia bark, sanchi and sargentgloryvine stem. The Chinese medicinal composition can effectively improve blood supply and circulation of organs and limbs, can improve and regulate the permeability of micro-circulating capillary, and has the effects of promoting circulation of vital energy, notifying kidney, dredging collaterals, dissolving stasis and relieving pains.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, be specifically related to a kind of Chinese medicine composition for the treatment of hyperosteogeny.
Background technology
Hyperosteogeny is the higher a kind of disease of present sickness rate, the serious harm patient health.The clinical a series of pathological changes such as upper limb paralysis, shoulder and back ache, difficulty in walking that mainly show as.
At present, treatment
Hyperosteogeny mainly adopts physical therapy, ultraviolet therapy, massage and traction, acupuncture-moxibustion, western medicine, operative treatment, treatment by Chinese herbs etc.Because this disease belongs to frequently-occurring disease, commonly encountered diseases, and Western medicine does not have comparatively ideal Therapeutic Method, so domestic in recent years a large amount of this disease of utilization traditional Chinese medical herbal treatment.Though prior art discloses the Chinese medicine preparation of many treatment hyperosteogenys, but still need eutherapeutic Chinese medicine composition.
Summary of the invention
The Chinese medicine composition that the purpose of this invention is to provide a kind of effective treatment hyperosteogeny.
The arthromyodynia category of the hyperosteogeny ownership traditional Chinese medical science.The traditional Chinese medical science thinks that hyperosteogeny one is that deficiency of both the liver and kidney, medicine are tired and hinders, and spasm of muscles and vessels, gos deep into muscles and bones and causes the cloudy skeleton that stagnates of congestion, grain, QI-blood circulation to be obstructed and to form wind-cold damp pathogen; The 2nd, plain body weakness, insufficiency of vital energy and blood is attacked passages through which vital energy circulates in the wind-cold damp pathogen, and the retardance meridians cause qi and blood stagnation, and are obstructed through then.
The inventor according to clinical experience for many years, has developed a kind of Chinese medicine composition of effective treatment hyperosteogeny on the basis of secret prescription handed down in the family from generation to generation.
The Chinese medicine composition that the present invention treats hyperosteogeny is to be made by the medicine of following weight ratio example:
Rhizoma Dioscoreae althaeoidis (Rhizoma Dioscoreae Nipponicae) 10-25 part, Rhizoma Drynariae 5-20 part, Herba Pyrolae 10-30 part, Rhizoma Cibotii 10-25 part, Cortex Eucommiae 10-25 part, Radix Notoginseng (Radix Notoginseng) 10-25 part, Caulis Sargentodoxae 1-5 part.
The preparation method that the present invention treats the Chinese medicine composition of hyperosteogeny is: Rhizoma Dioscoreae althaeoidis (Rhizoma Dioscoreae Nipponicae), Rhizoma Drynariae, Herba Pyrolae, Rhizoma Cibotii, the Cortex Eucommiae, Radix Notoginseng (Radix Notoginseng) are added the decocting that 3-10 doubly measures boil 2 times, each 0.5-2 hour, collecting decoction, make decoction, add the Caulis Sargentodoxae of pulverizing then.
The instructions of taking that the present invention treats the Chinese medicine composition of hyperosteogeny is:
Above Chinese medicine collecting decoction potion every day, 7 days is a course of treatment, cold water is fried in shallow oil after 1 hour and is taken, every day 3 times.
The medicinal function of medicine of the present invention is as follows:
Rhizoma Dioscoreae althaeoidis (Rhizoma Dioscoreae Nipponicae): bitter in the mouth, property is flat.Go into spleen, lung meridian.Relaxing muscles and tendons to promote blood circulation penetrates eliminating stagnation.
Rhizoma Drynariae: bitter in the mouth, warm in nature.Go into liver, kidney channel.Mend the bone pain relieving, the strong muscle of invigorating blood circulation.
Herba Pyrolae: sweet-bitter flavor, warm in nature.Go into liver, kidney channel.Nourishing liver, invigorating kidney, bone and muscle strengthening, expelling wind and removing dampness.
Rhizoma Cibotii: bitter but sweet flavor, warm in nature.Return liver, kidney channel.Invigorating the liver and kidney, strong waist knee joint, wind-damp dispelling.
The Cortex Eucommiae: sweet in the mouth, warm in nature.Return liver, kidney channel.Invigorating the liver and kidney, bone and muscle strengthening, controlling nocturnal emission with astringent drugs is calmed the nerves, blood pressure lowering.
Radix Notoginseng (Radix Notoginseng): sweet in the mouth, little hardship, warm in nature.Return liver, stomach warp.The dissipating blood stasis hemostasis, reducing swelling and alleviating pain.
Caulis Sargentodoxae: sweet-salty, property is flat.Go into the heart, Liver Channel.The dissipating blood stasis analgesic therapy, hemostasia and promoting granulation.
The said medicine synergism can effectively improve the blood supply and the circulation of internal organs and limbs, improves and regulate the permeability of microcirculation blood capillary, plays circulation of qi promoting, the kidney invigorating, collateral dredging, blood stasis dispelling, analgesic effect.
Medicine of the present invention uses through 620 clinical patients in the Yi-Hui Autonomous County of Weishan, Yunnan Province.The result of use evaluation table is as follows:
| Title | Percentage rate | Curative effect judging standard |
| Invalid | 5％ | Pain is invalid |
| Effectively | 10％ | Hypertrophy and lumbago alleviate part |
| Produce effects | 85％ | Hypertrophy pain is eliminated, and the soreness of waist is unable normal |
Model case
Money, woman, 35 years old.The prescription on individual diagnosis Attacking Midfielder can not directly rise, and foot is walked not go out.Take medicine of the present invention, serve on 6 days 1 dose of every day, waist straightens up, and fully recovers after obeying for 2 courses of treatment again.
Zhao, man, 40 years old.Can not stand before going to a doctor.Take medicine of the present invention, serve on 7 days 1 dose of every day, can stand, fully recover after 5 courses of treatment.
Shut out certain, man, 50 years old.Going to a doctor, preceding lumbago can not be bent over, foot numbness.Take medicine of the present invention, obey and alleviate after 7 days 1 dose of every day, fully recover after serveing on 5 courses of treatment.
The Wang, woman, 42 years old.Gnawing pains take no rest for prescription on individual diagnosis forward foot in a step fiber crops.Take medicine of the present invention, took medicine 3 days 1 dose of every day, pain relief, serve on 20 days after the recovery from illness.
The specific embodiment
Embodiment 1
In following ratio weighting raw materials:
Rhizoma Dioscoreae althaeoidis (Rhizoma Dioscoreae Nipponicae) 25g, Rhizoma Drynariae 10g, Herba Pyrolae 15g, Rhizoma Cibotii 10g, Cortex Eucommiae 25g, Radix Notoginseng 10g, Caulis Sargentodoxae 2g.
The decocting that Rhizoma Dioscoreae althaeoidis (Rhizoma Dioscoreae Nipponicae), Rhizoma Drynariae, Herba Pyrolae, Rhizoma Cibotii, the Cortex Eucommiae, Radix Notoginseng is added 5 times of amounts boils each 45 minutes 2 times.Collecting decoction is made decoction.Caulis Sargentodoxae is made powder, swallow with decoction.
Embodiment 2
In following ratio weighting raw materials:
Rhizoma Dioscoreae althaeoidis (Rhizoma Dioscoreae Nipponicae) 15g, Rhizoma Drynariae 15g, Herba Pyrolae 20g, Rhizoma Cibotii 15g, Cortex Eucommiae 20g, Radix Notoginseng 15g, Caulis Sargentodoxae 2g.
The decocting that Rhizoma Dioscoreae althaeoidis (Rhizoma Dioscoreae Nipponicae), Rhizoma Drynariae, Herba Pyrolae, Rhizoma Cibotii, the Cortex Eucommiae, Radix Notoginseng is added 8 times of amounts boils each 60 minutes 2 times.Collecting decoction is made decoction.Caulis Sargentodoxae is made powder, swallow with decoction.
Embodiment 3
In following ratio weighting raw materials:
Rhizoma Dioscoreae althaeoidis (Rhizoma Dioscoreae Nipponicae) 20g, Rhizoma Drynariae 25g, Herba Pyrolae 10g, Rhizoma Cibotii 20g, Cortex Eucommiae 15g, Radix Notoginseng 5g, Caulis Sargentodoxae 2g.
The decocting that Rhizoma Dioscoreae althaeoidis (Rhizoma Dioscoreae Nipponicae), Rhizoma Drynariae, Herba Pyrolae, Rhizoma Cibotii, the Cortex Eucommiae, Radix Notoginseng is added 8 times of amounts boils each 60 minutes 2 times.Collecting decoction is made decoction.Caulis Sargentodoxae is made powder, swallow with decoction.
Claims (2)
1. Chinese medicine composition for the treatment of hyperosteogeny is characterized in that: be to be made by the medicine of following weight ratio example:
Rhizoma Dioscoreae althaeoidis 10-25 part, Rhizoma Drynariae 5-20 part, Herba Pyrolae 10-30 part, Rhizoma Cibotii 10-25 part, Cortex Eucommiae 10-25 part, Radix Notoginseng 10-25 part, Caulis Sargentodoxae 1-5 part.
2. the Chinese medicine composition of treatment hyperosteogeny according to claim 1, it is characterized in that: its preparation method is: Rhizoma Dioscoreae althaeoidis, Rhizoma Drynariae, Herba Pyrolae, Rhizoma Cibotii, the Cortex Eucommiae, Radix Notoginseng are added the decocting that 3-10 doubly measures boil 2 times, each 0.5-2 hour, collecting decoction, make decoction, add the Caulis Sargentodoxae of pulverizing then.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102203029A CN101703664B (en) | 2009-12-01 | 2009-12-01 | Chinese medicinal composition for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102203029A CN101703664B (en) | 2009-12-01 | 2009-12-01 | Chinese medicinal composition for treating hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101703664A CN101703664A (en) | 2010-05-12 |
| CN101703664B true CN101703664B (en) | 2011-04-13 |
Family
ID=42373961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102203029A Expired - Fee Related CN101703664B (en) | 2009-12-01 | 2009-12-01 | Chinese medicinal composition for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101703664B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413680A (en) * | 2002-10-21 | 2003-04-30 | 罗孝华 | Chinese medicine for treating hyperosteogeny |
-
2009
- 2009-12-01 CN CN2009102203029A patent/CN101703664B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413680A (en) * | 2002-10-21 | 2003-04-30 | 罗孝华 | Chinese medicine for treating hyperosteogeny |
Non-Patent Citations (1)
| Title |
|---|
| 荆云.中成药治疗痹证的研究近况.《云南中医学院学报》.2003,第26 卷(第3 期),39-42，48. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101703664A (en) | 2010-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100546644C (en) | A kind of external herb liquid for the treatment of pain caused by wind, cold and damp | |
| CN101972453B (en) | Chinese medicinal liquor for treating rheumatic and rheumatoid arthritis and preparation method thereof | |
| CN101766773A (en) | Chinese medicine prescription for treating talagia | |
| CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
| CN104740142A (en) | Traditional Chinese medicine for treating sciatica | |
| CN103099879B (en) | Traditional Chinese medicine (TCM) preparation for treating fifth-watch diarrhea | |
| CN103041085B (en) | Traditional Chinese medicine composition for treating dysmenorrheal by lavipeditum nursing and application | |
| CN102441131A (en) | Chinese medicinal composition for treating traumatic injury | |
| CN101703664B (en) | Chinese medicinal composition for treating hyperosteogeny | |
| CN101708266B (en) | Oral herbal decoction for treating osteoporosis | |
| CN104740003A (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN103860735B (en) | The Chinese medicine, Chinese medicine composition and preparation method thereof for the treatment of sciatica and lumbago | |
| CN102988833A (en) | Traditional Chinese medicine composition for treating rheumatism | |
| CN100548336C (en) | A kind of Chinese medicine composition of orally taken for curing intercostal neuralgia | |
| CN102961527B (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN100594916C (en) | Plaster for reducing the blood pressure | |
| CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
| CN106421614A (en) | Spleen-invigorating, collateral-dredging and detoxifying traditional Chinese medicinal capsule | |
| CN107233394A (en) | One kind cures diabetic acromelic gangrene foot disease bath prescription | |
| CN106110215A (en) | A kind of medicine treating varicose veins of the lower extremity | |
| CN104740193A (en) | Traditional Chinese medicine composition for treating neck-shoulder muscle strain syndrome and preparation method of traditional Chinese medicine composition | |
| CN105521391A (en) | Traditional Chinese medicine for tonifying liver and kidney and for strengthening bones and muscles and preparation method of traditional Chinese medicine | |
| CN104436060A (en) | Traditional Chinese medicine formula for nursing and treating cholangiocellular carcinoma and preparation method of traditional Chinese medicine formula | |
| CN104689109A (en) | Traditional Chinese medicine decoction for treating hypertension | |
| CN103948804B (en) | A kind of Chinese medicine composition treating lung qi deficiency dermatitis aestivale |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Xingfu Document name: Review of business letter |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice |
Addressee: Shi Haixiu Document name: Notice of termination of patent right |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110413 Termination date: 20201201 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |